E-learning in order to improve drug prescription for hospitalized older patients: a cluster-randomized controlled study

Br J Clin Pharmacol. 2016 Jul;82(1):53-63. doi: 10.1111/bcp.12922. Epub 2016 Apr 5.

Abstract

Aims: The aim of the study was to evaluate the effect of an e-learning educational program meant to foster the quality of drug prescription in hospitalized elderly patients.

Methods: Twenty geriatric and internal medicine wards were randomized to intervention (e-learning educational program) or control (basic geriatric pharmacology notions). Logistic regression analysis was used in order to assess the effect of the intervention on the use of potentially inappropriate medication (PIM, primary outcome) at hospital discharge. Secondary outcomes were a reduced prevalence of at least one potential drug-drug interaction (DDI) and potentially severe DDI at discharge. Mortality rate and incidence of re-hospitalizations were other secondary outcomes assessed at the 12-month follow-up.

Results: A total of 697 patients (347 in the intervention and 350 in the control arms) were enrolled. No difference in the prevalence of PIM at discharge was found between arms (OR 1.29 95%CI 0.87-1.91). We also found no decrease in the prevalence of DDI (OR 0.67 95%CI 0.34-1.28) and potentially severe DDI (OR 0.86 95%CI 0.63-1.15) at discharge, nor in mortality rates and incidence of re-hospitalization at 12-month follow-up.

Conclusions: This e-learning educational program had no clear effect on the quality of drug prescription and clinical outcomes in hospitalized elderly patients. Given the high prevalence of PIMs and potential DDIs recorded in the frame of this study, other approaches should be developed in order to improve the quality of drug prescription in this population.

Trial registration: ClinicalTrials.gov NCT02339792.

Keywords: E-learning; comprehensive geriatric assessment; drug prescription; drug-drug interaction; elderly people; potentially inappropriate medication.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Drug Interactions
  • Drug-Related Side Effects and Adverse Reactions / prevention & control*
  • Education, Medical, Continuing / methods*
  • Female
  • Follow-Up Studies
  • Hospitalization
  • Humans
  • Inappropriate Prescribing / prevention & control*
  • Internet
  • Logistic Models
  • Male
  • Patient Discharge
  • Practice Patterns, Physicians' / standards*
  • Prevalence
  • Single-Blind Method

Associated data

  • ClinicalTrials.gov/NCT02339792